IFNA1 and Sjogren syndrome: There are still many questions left unanswered regarding the clinical aspects of BL-7040, including a more detailed clinical and histolopathological assessment of the patients, analysis of AChE levels and local IFNα production, and the association of non-canonical NFkB markers with different stages of Sjogren's syndrome.